Compare BDTX & RBKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDTX | RBKB |
|---|---|---|
| Founded | 2014 | 1860 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.1M | 130.0M |
| IPO Year | 2020 | 2019 |
| Metric | BDTX | RBKB |
|---|---|---|
| Price | $2.67 | $11.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.60 | N/A |
| AVG Volume (30 Days) | ★ 931.3K | 7.1K |
| Earning Date | 03-05-2026 | 01-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.38 | ★ 0.46 |
| Revenue | ★ $70,000,000.00 | $45,306,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $7.07 | $26.28 |
| Revenue Growth | N/A | ★ 54.93 |
| 52 Week Low | $1.20 | $9.31 |
| 52 Week High | $4.94 | $13.99 |
| Indicator | BDTX | RBKB |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 52.11 |
| Support Level | $2.56 | $11.56 |
| Resistance Level | $2.83 | $12.10 |
| Average True Range (ATR) | 0.14 | 0.30 |
| MACD | 0.06 | -0.09 |
| Stochastic Oscillator | 56.47 | 39.01 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one-to four-family residential real estate loans, and to purchase investment securities.